Steven Haller remembers the look of fear on people’s faces when toxic algae in Lake Erie made it into his community’s water supply 10 years ago, shutting it down for two days. Since then, Haller, a ...
Genelux Corporation (NASDAQ: GNLX), a late-stage clinical immuno-oncology company, today announced that the first patient has been dosed in the U.S.-based Phase 2 (VIRO-25) trial evaluating ...